PsychoGenics: PsychoGenics secures NIH contract to identify new pain therapeutics

The contract, with a maximum value of $80m over a five-year period, is part of the NIH's Helping to End Addiction Long-term Initiative (HEAL Initiative) and falls under The post PsychoGenics secures NIH contract to identify new pain therapeutics appeared first on Pharmaceutical Business review.